Indications
Therapeutic Asset Ratings
9,920 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Re-Stimulated Tumor-Infiltrating Lymphocytes
Ovarian Cancer
University Health Network, Toronto
P1
CC
(43)
Retifanlimab
Digestive System Neoplasm
Incyte Corporation
P1
CC
(43)
Retifanlimab
B-Cell Non-Hodgkin Lymphoma
University of Alabama at Birmingham
P1
CC
(43)
Revdofilimab
Non-Small Cell Lung Carcinoma
AbbVie
P1
CC
(43)
rg6496
Huntington Disease
Hoffmann-La Roche
P1
CC
(43)
Rgt-490
Her2-Receptor Negative Breast Cancer
Regor Pharmaceuticals Inc.
P1
CC
(43)
Rgt-61159
Adenoid Cystic Carcinoma
Rgenta Therapeutics Inc
P1
CC
(43)
rgv004
B-Cell Non-Hodgkin Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
P1
CC
(43)
Rhdnase I
Large B-Cell Lymphoma
Tel-Aviv Sourasky Medical Center
P1
CC
(43)
Rhenium (¹??Re) Obisbemeda
Neoplastic Meningitis
Plus Therapeutics
P1
CC
(43)
Ribociclib
Acute Lymphoblastic Leukemia
Dana-Farber Cancer Institute
P1
CC
(43)
Ribociclib
Esophageal Adenocarcinoma
Blueprint Medicines Corporation
P1
CC
(43)
Ribociclib
Gastric Cancer
Blueprint Medicines Corporation
P1
CC
(43)
Ribociclib
Lung Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
P1
CC
(43)
Ricolinostat
B-Cell Chronic Lymphocytic Leukemia
Dana-Farber Cancer Institute
P1
CC
(43)
Rifaldazine
Refractory Malignant Neoplasm
Qilu Pharmaceutical Co., Ltd.
P1
CC
(43)
Riluzole
Melanoma
National Cancer Institute (NCI)
P1
CC
(43)
Riluzole
Refractory Malignant Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
Rilvegostomig
Cancer
AstraZeneca
P1
CC
(43)
Rimiducid
Diffuse Large B-Cell Lymphoma
Poseida Therapeutics, Inc.
P1
CC
(43)
Rimiducid
Epstein-Barr Virus Infection
Baylor College of Medicine
P1
CC
(43)
Rimiducid
Hereditary Hemophagocytic Lymphohistiocytosis
Baylor College of Medicine
P1
CC
(43)
Rimiducid
Immune System Disorder
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Rimiducid
Immunoproliferative Disorder
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Rimiducid
Lymphatic System Disorder
UNC Lineberger Comprehensive Cancer Center
P1
CC
(43)
Showing 4051 to 4075 of 9,920 assets
Previous
Page 163 of 397
Next